Smoking remains the leading preventable cause of premature death globally, and the persistent gap between quit attempts and quit success has driven researchers to re-examine every available tool. A Cochrane systematic review—the gold standard for synthesizing evidence—now positions nicotine e-cigarettes ahead of traditional nicotine replacement therapies (NRT) in helping adults stop smoking, a finding with real implications for the estimated one billion people still smoking worldwide.
The updated Cochrane review pooled data from randomized controlled trials comparing nicotine e-cigarettes against conventional NRT (patches, gum, lozenges) and against unaided cessation with or without behavioral support. Across the included trials, participants assigned to nicotine vapes demonstrated higher rates of sustained smoking abstinence than those using traditional NRT. The review updated an earlier Cochrane analysis and incorporated newer high-quality trial data, strengthening confidence in the direction of the effect—though absolute quit rates remain modest, consistent with cessation pharmacotherapy literature broadly.
This finding challenges a long-standing clinical conservatism around e-cigarettes, which many physicians have been reluctant to recommend due to concerns about unknown long-term pulmonary effects and dual use (vaping while continuing to smoke). The Cochrane methodology, however, prioritizes cessation outcomes rather than speculative harms, and this distinction matters for clinical practice. It is worth noting that e-cigarettes are not risk-free; displacing combustible cigarettes reduces exposure to thousands of carcinogens, but nicotine dependence may simply shift form rather than resolve. Longer follow-up data—beyond the typical 6–12 month trial horizon—are still needed to determine whether vapers eventually achieve full nicotine independence or sustain dual use. For high-volume smokers who have failed conventional NRT, this evidence supports a conversation with their physician about vaping as a cessation bridge, not a destination.